In South Kivu, Democratic Republic of Congo, a new challenge is disrupting healthcare. Funding withdrawals are making vital care inaccessible, particularly for pregnant women and newborns. Read our latest press release here ⬇️

From five ways to improve vaccine access to outrage over pharma failing to address the barriers stopping people from accessing HIV prevention medication, explore our call for disease prevention not to be a privilege in our latest MSF Access newsletter: msfaccess.org/newsletter/f...

We are pleased to welcome Kris Torgeson as the incoming Executive Director of MSF Access.

Also discussed last week with @msfaccess.org on @sabcnews.bsky.social Channel Africa 🎧 omny.fm/shows/africa...

In 2024, half of the 14.3 million children who missed out on receiving any vaccination lived in countries affected by conflict, fragility, or humanitarian crises. It's time to close this gap through timely access to vaccines for all children, everywhere. #WorldImmunizationWeek

Neglected diseases are estimated to affect >1 billion people. However, there's limited attention and funding into vaccine research & development for these diseases. Safe & effective vaccines would be impactful in reducing the burden of neglected diseases. #WorldImmunisationWeek

Each year, over a quarter of a million children acquire chronic hepatitis B at birth, resulting in many premature deaths. If every newborn received hepatitis B birth dose – an affordable vaccine supported by Gavi – these deaths could be prevented. #WorldImmunizationWeek

Investing in innovations like vaccine Microarray Patches could help overcome barriers to reaching people in remote, conflict-affected, and fragile settings with vaccination. #WorldImmunisationWeek

Tuberculosis continues to kill more than 1 million people each year. A safe, effective, and affordable vaccine to protect adolescents and adults against #tuberculosis would be a significant step towards reducing global mortality due to TB. #WorldImmunizationWeek

This World Immunisation Week (24-30 April), we’ll be sharing five videos featuring MSF staff highlighting key pathways to reach more people with lifesaving vaccines. Stay tuned.

No more one-sided deals. As WHO talks reach a critical stage, MSF writes to the EU to ensure pathogen and data sharing comes with binding commitments to access to medical tools for people who need them most. msfaccess.org/open-letter-...

People in many countries with high HIV rates can’t access lenacapavir as prices remain too high and Gilead tightly controls its supply and production.

Gilead’s latest announcement on lenacapavir to provide injectable pre-exposure prophylaxis (PrEP) to up to one million more people in three years falls far short of what's needed to make a real dent in HIV transmission globally.

Gilead announcement does not address reasons people can’t access groundbreaking HIV prevention medicine www.doctorswithoutborders.org/latest/gilea...

Across Africa, funding constraints for research & development (R&D) are taking effect. In Feb 2026, we convened experts to discuss the now urgent need to build a more equitable and sustainable R&D ecosystem in Africa. Read our report 👉 msfaccess.org/shifting-glo...

Argentina has revoked key pharmaceutical patentability guidelines, a roll-back that could create and extend more monopolies, and, ultimately, delay or deny people’s access to affordable healthcare. healthpolicy-watch.news/argentina-ha...

🦠 The impact of antimicrobial resistance (#AMR) in conflict-affected settings is severe.    The full report brings together practitioner experiences and offers ways to address AMR in some of the most fragile contexts, with lessons relevant worldwide. 👉 msfaccess.org/antimicrobia...

New MSF analysis sheds light on how monoclonal antibodies can increase protection for people after exposure to Ebola. What’s needed now is more research and improved access to this promising treatment for healthcare workers and community members. revuemtsi.societe-mtsi.fr/index.php/bs...

Before the diagnosis, Hareem and Ahmad were often unwell. They had poor appetite, abdominal pain, irritability, and were becoming weak. Their mother had taken them to a nearby clinic where they were given medicines without proper diagnosis, but their condition did not improve.

The Head of the Paediatrics Department at Gujranwala Teaching Hospital (Pakistan), Dr Saima Umar, shares her experience of how WHO Treatment Decision Algorithms are helping diagnose children with #tuberculosis more effectively and the challenges doctors faced before their introduction.

Despite Gilead’s public claims that it can expand production of lenacapavir to meet needs, the company has refused requests from MSF to purchase a limited supply for use in our programs. Read our open letter to Gilead here: www.doctorswithoutborders.org/latest/preve...

NEW: US pharmaceutical corporation Gilead Sciences is refusing to sell groundbreaking HIV prevention drug to MSF.

“AMR in conflict or humanitarian settings is right there. It’s in front of us. We're already dealing with it.” Dr Kalyan Velivela, MSF health programme manager for South Sudan, Ethiopia, and Nigeria. Addressing AMR in humanitarian settings means acting on our shared experiences.

On #WorldTBDay, MSF urges governments and donors to put children at the heart of the global TB response. Sustained funding is needed to diagnose, treat, and prevent TB in children, who remain one of the most vulnerable groups.    msfaccess.org/msf-demands-...

Why half of the 1.2 million children with TB cannot access diagnosis and lifesaving treatment? Watch this video to learn more. #WorldTBDay     www.youtube.com/watch?v=6k6Y...

Drawing on MSF’s frontline experience across emergencies, we’re calling on EU to progress towards a system that ensures fair and equitable benefit‑sharing in exchange for access to pathogens and genetic resources used in R&D, including clinical trials. msfaccess.org/msf-calls-eu...

In 2011, more than 3,000 people marched in India to oppose harmful provisions that could have been included in EU–India free trade agreement and threatened access to affordable medicines. Fifteen years later, after two decades of sustained advocacy, those were excluded from the final deal.

India-EU free trade agreement full text has been released and the intellectual property chapter: 👍Largely preserves India’s public health safeguards and doesn't go beyond @wto.org TRIPS agreement 🛑 BUT 🛑

In 2014, I visited eastern DRC, where @msf.org teams were treating sleeping sickness - the only available treatment was a drug so toxic it killed 1 in 20 patients. In 2026 I'm so proud that, thanks to @dndi.org, patients can be cured with a single dose of a groundbreaking new oral drug, acoziborole.

🚀 Huge news for people living with #sleepingsickness! Acoziborole, a one-day, single-dose oral treatment developed with Sanofi, has received a positive opinion from @ema.europa.eu for the treatment of the most common form of sleeping sickness. 👉 bit.ly/46ZFpEi

Thanks @madhupai.bsky.social for the spotlight on TB in Europe. Additionally, lack of access to treatment due to unavailability, high prices, and fragmented supply of TB medicines remains a major challenge. Critical DR-TB meds are exorbitantly priced in the region: some over 100x than in LMICs!

Read MSF’s recommendations for a strong WHO Pathogen Access and Benefit-Sharing (PABS) system calling for reliable, equitable and accountable access to vaccines, diagnostics and treatments developed from shared samples and data. msfaccess.org/ensuring-col...

👉 @msfbrasil.bsky.social is seeking to intervene in a Supreme Court case challenging Brazil’s new law on research, which limits the right of clinical trial participants to receive free access to medicines developed from the studies they joined.

MSF representatives addressed critical issues in fragile settings at the @who.int Executive Board #EB158 this week, calling for urgent action on: 🔹Antimicrobial resistance (AMR) 🔹Mental health 🔹Noncommunicable diseases (NCDs) 🔹Vaccines Read the statements: msfaccess.org/msf-statemen...

...and the harmful consequences of the Trump administration’s drive to reshape US foreign assistance have only just started to unfold.

Great read: an MSF reflection on antimicrobial evidence gaps and implementation needs in humanitarian settings, grounded in MSF's work in fragile contexts.

Why is #insulin, an essential and lifesaving medication that’s existed for over 100 years, still priced, patented, and distributed like a 💎luxury good💎? Listen as our advocacy advisor, Candice Sehoma, unpacks it on this #podcast episode: open.spotify.com/episode/6p39...

From Forest to Factory analyzes global supply chains for 2 critical vaccine adjuvants, QS-21 and MPL — used in vaccines for malaria, shingles, RSV, & a leading tuberculosis vaccine candidate. Read the full report here: www.treatmentactiongroup.org/publication/...

Yesterday, 175 governments pledged to accelerate responses to NCDs & mental health. Now they must take concrete actions to ensure everyone has affordable access to the medical tools they need. msfaccess.org/governments-...

Do you know how #algorithms can help diagnose the world's deadliest infectious disease? Find out in our latest newsletter 👇 msfaccess.org/newsletter/a...

Along with 10 other civil society organisations, we sent an open letter to the European Parliament’s Committee on Public Health, sharing recommendations to ensure that the Critical Medicines Act advances equitable access for all. msfaccess.org/cso-open-let...

Yesterday, at Abrascão, Brazil's largest public health congress, MSF Access' Marcela Vieira explored how patent monopolies raise prices, limit access to health products, and deepen health inequities... and she shared a way to challenge them: www.patentoppositions.org

Novo Nordisk discontinues key insulin products in EU/EEA for commercial reasons: “Yet another unacceptable example of pharmaceutical corporations putting profits before people’s health.” msfaccess.org/msf-responds...

Negotiations on the Pathogen Access and Benefit Sharing (PABS) system, a key aspect of the WHO Pandemic Agreement adopted in May this year, began today. Read our statement and asks: msfaccess.org/msf-welcomes...

Happening tomorrow!

On World Children’s Day (20 Nov 2025), TB activists and MSF marched in solidarity with children affected by tuberculosis at the Union World Conference on Lung Health in Copenhagen. To learn more about MSF’s work and engagement on TB in children, visit: www.msf.org/tactic-tuber...

On #WorldAMRAwarenessWeek, we’re calling for concrete action to ensure access to existing diagnostic tools, microbiology capacities, legacy & new lifesaving antibiotics, and care for all... + an increase in R&D for low-resource & humanitarian settings, where it's most needed.

🦠 By 2050, AMR is estimated to contribute to 8.2 million deaths worldwide. For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe. #WorldAMRAwarenessWeek

AMR, FTAs, TB, do you know what these acronyms mean, and what they have to do with access to health products? If you're curious, read our latest newsletter, and sign up for more access content! msfaccess.org/newsletter/a...

This World AMR Awareness Week, join a discussion on antimicrobial resistance in conflict-affected settings, where AMR's impact is severe due to limited access to infection prevention, diagnostics, and antimicrobials. 📅 Thur 20 Nov 🕐 13:30 – 15:00 CET fao.zoom.us/webinar/regi...